FBRX Archived Articles
Forte Biosciences (NASDAQ:FBRX): Advancing Autoimmune Therapies with Promising Clinical Progress
Published on November 30, 2024
Forte Biosciences, Inc. (FBRX): Navigating the Challenges of Autoimmune Disease Development
Published on September 24, 2024